文章摘要
姜耘宙,汪正明,王瑞,等.β-谷甾醇改善绝经后骨质疏松的实验研究[J].浙江中医药大学学报,2024,48(2):131-137, 146.
β-谷甾醇改善绝经后骨质疏松的实验研究
Study on the Intervention Effect of β-sitosterol in the Postmenopausal Osteoporosis
DOI:10.16466/j.issn1005-5509.2024.02.001
中文关键词: 绝经后骨质疏松症  β-谷甾醇  杜仲  骨形成  成骨细胞  β-catenin
英文关键词: postmenopausal osteoporosis  β-sitosterol  Eucommia ulmoides  bone formation  osteoblast  β-catenin
基金项目:2024年度浙江省中医药科技计划 (中医药临床研究计划项目)(2024ZL044)
作者单位
姜耘宙 浙江中医药大学附属金华中医院 浙江金华 321017 
汪正明 上海中医药大学附属曙光医院
浙江中医药大学 
王瑞 浙江中医药大学 
项思成 浙江中医药大学 
金钊锴 浙江中医药大学 
童培建 浙江中医药大学附属第一医院浙江省中医院 
吕帅洁 浙江中医药大学附属第一医院浙江省中医院 
摘要点击次数: 387
全文下载次数: 226
中文摘要:
      [目的] 探究杜仲有效单体成分β-谷甾醇对小鼠绝经后骨质疏松的疗效及其潜在作用机制。[方法] 将24只12周龄雌性C57BL/6J小鼠随机分为假手术组、模型组及β-谷甾醇干预组,每组8只,采用双侧卵巢切除术建立绝经后骨质疏松模型,术后假手术组及模型组给予0.9%氯化钠溶液灌胃,β-谷甾醇干预组给予β-谷甾醇灌胃,术后8周将各组小鼠处死取材,借助显微计算机断层扫描(micro-computed tomography,Micro-CT)观察β-谷甾醇干预对绝经后骨量丢失及骨小梁破坏的保护作用,并采用苏木素-伊红(hematoxylin-eosin,HE)染色对小鼠股骨远端区域进行组织形态学分析,同时通过抗酒石酸酸性磷酸酶(tartrate-resistant acid phosphatase,TRAP)染色及碱性磷酸酶(alkaline phosphatase,ALP)染色评估小鼠骨吸收与骨形成情况,并通过免疫组化检测各组样本的β-catenin表达水平。[结果] Micro-CT扫描结果显示,β-谷甾醇干预可减少绝经后骨量丢失及骨微结构破坏,HE染色证实β-谷甾醇可有效维持骨小梁数目及组织形态,并在一定程度上抑制雌激素缺乏引起的异常脂肪堆积现象。TRAP染色结果表明,β-谷甾醇并不影响破骨细胞形成,而免疫组化结果表明β-谷甾醇可显著促进成骨标志物ALP的表达。与此同时,β-谷甾醇可增加β-catenin在股骨远端区域的表达,提示β-谷甾醇促进骨形成,可能与其上调β-catenin信号通路有关。[结论] β-谷甾醇体内干预可上调β-catenin信号通路,增强成骨分化,促进机体骨形成,从而改善绝经后骨质疏松。
英文摘要:
      [Objective] To explore the intervention effect of β-sitosterol, an effective monomer component of Eucommia ulmoides, on postmenopausal osteoporosis in mice and its potential mechanism. [Methods] Twenty-four female C57BL/6J mice of 12 weeks old were randomly divided into sham operation group, model group and β-sitosterol intervention group, with 8 mice in each group. The model of postmenopausal osteoporosis was established by bilateral ovariectomy. Mice in sham group and model group were given 0.9% sodium chloride solution and β-sitosterol intervention group was given β-sitosterol. Eight weeks after operation, all the mice were sacrificed and samples were collected. Micro-computed tomography(Micro-CT) was used to observe the protective effect of the β-sitosterol intervention on postmenopausal bone loss and trabecular bone breakage. Hematoxylin-eosin(HE) staining was used to analyze the bone histomorphology of the distal femur. The tartrate-resistant acid phosphatase(TRAP) staining and the alkaline phosphatase(ALP) staining were used to evaluate bone resorption and bone formation respectively. Then the expression level of β-catenin in each group was detected by immunohistochemistry. [Results] Micro-CT scanning showed that β-sitosterol could reduce bone loss and bone microstructure destruction in postmenopausal mice. HE staining also confirmed that β-sitosterol could effectively maintain the number and morphology of trabecular bone and inhibit abnormal fat accumulation caused by estrogen deficiency. TRAP staining also showed that β-sitosterol treatment did not affect osteoclast formation, while immunohistochemical results showed that β-sitosterol could significantly promote the expression of osteogenic marker ALP. Moreover, β-sitosterol can increase the expression of β-catenin in the distal femur to promote bone formation. [Conclusion] β-sitosterol treatment could enhance osteogenic differentiation and promote bone formation to relieve postmenopausal osteoporosis by upregulating β-catenin expression in vivo.
查看全文   查看/发表评论  下载PDF阅读器
关闭